Oculus Innovative Sciences Announces Allowance of New Patent in Mexico for Novel Solution for Use in Invasive Surgical Procedures Jul 2, 2013
Oculus Innovative Sciences Reports Revenues of $15.5 Million for Fiscal Year 2013, Product Revenue Up 23 Percent Jun 13, 2013
Oculus Innovative Sciences Announces Two Key Agreements With Company's Subsidiary, Ruthigen, Inc. Jun 6, 2013
Oculus Announces Confidential Submission of Draft Registration Statement for Initial Public Offering to Securities and Exchange Commission by Its Subsidiary Ruthigen, Inc. May 28, 2013
Oculus Innovative Sciences Announces Fiscal Fourth Quarter 2013 Financial Results and Conference Call May 23, 2013
Oculus Innovative Sciences Announces New Regulatory Approvals for Microcyn(R)-Based Antiseptic Products in Panama and El Salvador May 1, 2013
Oculus Innovative Sciences Announces New Regulatory Approvals and Target Launch Dates for Three New Microcyn(R)-Based Products in Middle East Countries Apr 24, 2013
Oculus Innovative Sciences to Rollout Five New Microcyn(R) Technology-Based Products in Singapore and Malaysia Apr 10, 2013
Oculus Innovative Sciences Strengthens Intellectual Property Portfolio With Issuance of Three New International Patents for Microcyn(R) Technology Apr 4, 2013
